Methodological Issues in Study of Daily Insulin Dose and Cancer Risk Among Patients With Type 1 Diabetes-Reply

JAMA Oncol. 2023 Feb 1;9(2):283-284. doi: 10.1001/jamaoncol.2022.6831.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 1* / complications
  • Diabetes Mellitus, Type 1* / drug therapy
  • Humans
  • Insulin / adverse effects
  • Neoplasms* / drug therapy
  • Neoplasms* / epidemiology
  • Risk

Substances

  • Insulin